GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed a copy of newspaper publication of Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2023 as published in the Newspaper - The Free Press Journal (English) and Navshakti (Marathi). FY23 Annual Result Announced for Genesys International Corporation Ltd.
IT Consulting & Software company Genesys International Corporation announced FY23 results: The company’s traction on its content program remains strong Standalone Revenue from 12MFY23 has exceeded full-year FY22 revenue by 50.24% Standalone EBITDA in FY23 stood at Rs 64.85 crore, an increase of Rs 32.38 crore, 99.75% EBITDA Margin for FY23 maintained at 37% Standalone PAT in FY23 stood at Rs 38.46 crore, a YoY increase of 145.58% Net Profit attributable to Genesys (Parent) has increased from Rs 13.41 crore in FY22 to Rs 19.08 crore, in FY23 registering an increase of 42% on a YoY basis Genesys has increased its shareholding in A N Virtual World from 66% to 97.50% during the year Commenting on the results, Sajid Malik – Chairman & Managing Director said, “Our improved financial performance is a function of the pivot in our business model and the investments we have made in the digital twin space . Our partnerships with world leaders and several path breaking geo content work we have undertaken in this year manifest in our financial results . Digital twins / 3D modelling of the world will become a key part of what digitisation is paving the way to engage and govern our world in more efficient ways.” Result PDF GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Disclosure Of Related Party Transactions For The Quarter And Half Year Ended March 31, 2023 Pursuant To Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
In accordance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the quarter and half year ended March 31, 2023. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In continuation of our letter dated May 30, 2023 on the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2023, please find enclosed a copy of Press Release being issued by the Company in this regard. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 30, 2023
In compliance with the provisions of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company. 1. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023 along with the statement of Assets and Liabilities as at March 31, 2023. a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023. b. Auditors' Report along with a Declaration in respect of unmodified opinion on the Audited Financial Results. 2. Appointment of M/s H. C Vora & Associates as the Internal Auditors and M/s Roy Jacob & Co., Company Secretaries as the Secretarial Auditors of the Company for the financial year 2023-24. 3. Incorporation of a subsidiary based at Kingdom of Saudi Arabia in the name and style 'Genesys Middle East Limited'. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Results- Financial Results For The Quarter And Financial Year Ended March 31, 2023.
In compliance with the provisions of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company, at their meeting held today has inter alia considered and approved following:- 1. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023 a. Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2023. b. Auditors' Report along with a Declaration in respect of unmodified opinion on the Audited Financial Results. 2. Appointment of M/s H. C Vora & Associates as the Internal Auditors and M/s Roy Jacob & Co., Company Secretaries as the Secretarial Auditors of the Company for the financial year 2023-24. 3. Incorporation of a subsidiary based at Kingdom of Saudi Arabia in the name and style 'Genesys Middle East Limited'. The meeting of Board commenced at 7.00 p.m. and concluded at 9.00p.m. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations, 2015 For The Quarter And Financial Year Ended March 31, 2023
In compliance with the Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 please find attached the Statement of Deviation or Variation or Utilization of funds raised through Preferential Issue by the Company for the quarter and financial year ended March 31, 2023 as reviewed by the Audit Committee. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/ CMD1/27/2019 dated February 08, 2019, we are enclosing herewith the Annual Secretarial Compliance Report issued by M/s Roy Jacob & Co., Company Secretaries for the Financial Year 2022-23. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Intimation Of Board Meeting To Approve The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2023.
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Pursuant to the provisions under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, rules and regulations, if any, this is to inform you that a meeting of the Board of Directors of the Company will be held at registered office on Tuesday, May 30, 2023, to inter alia consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2023.